Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Stock Movers: Rheinmetall, Lufthansa, Zealand Pharma
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street. Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for…
Truist Raises Its Price Target on BridgeBio Pharma, Inc. (BBIO) to $95 and Maintains a Buy Rating
BridgeBio Pharma, Inc. (NASDAQ: BBIO) is among the 10 Fastest Growing NASDAQ Stocks to Buy. On February 25, 2026, Truist analyst Danielle Brill raised the firm's price target on BridgeBio Pharma, Inc. (NASDAQ:BBIO) to $95 from $86 and maintained a…
Altimmune Reports FY25 Financials: Why Is Big Pharma Staying Away (NASDAQ:ALT)
Altimmune (ALT) is advancing pemvidutide, a dual GLP-1/glucagon agonist, into a pivotal Phase 3 MASH trial in 2026. ALT secured $340M in cash, providing a 2.5-year runway to support late-stage clinical development and operational milestones.
Alembic enters US branded pharma space; commences sale of antibiotic
Alembic Pharmaceuticals on Friday said it has commenced sales of an oral penicillin-class antibiotic in the US market. The company has commenced sales of Pivya (pivmecillinam) tablets following its recent commercial launch in the US. Pivya is…
Fintech Sues Deutsche Bank, Pathward Over Pharma Flags
A self-described barter-based payment platform sued Deutsche Bank AG and Pathward NA, alleging it was improperly placed on an industry blacklist following the banks' assertions it was 'transaction laundering' for companies... To view the full…
William Blair Reiterates 'Market Perform' Rating for Zealand Pharma A/S (OTCMKTS:ZLDPF)
Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report)'s stock had its 'market perform' rating restated by analysts at William Blair in a research report issued on Friday. ZLDPF has been the subject of a number of other reports. Cantor Fitzgerald…
Astorg, EQT, TA, New Mountain active in pharma ingredients; Medical components manufacturing draws in dealmakers
A verification email is on its way to you. Please check your spam or junk folder just in case. If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email:.
Zealand Pharma A/S's (ZLDPF) Neutral Rating Reiterated at Cantor Fitzgerald
Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report)'s stock had its 'neutral' rating reaffirmed by stock analysts at Cantor Fitzgerald in a report issued on Friday. A number of other equities research analysts have also recently commented on the…
U.S. Futures, European Stocks Edge Up
U.S. futures for the S&P 500 were up 0.1% and futures for the Dow Jones Industrial Average increased 0.1%. Changes in futures do not necessarily predict movements after the opening bell. In Europe, the Stoxx Europe 600 climbed 0.2% in morning…
Zealand Pharma A/S (OTCMKTS:ZLDPF) Sets New 52-Week Low - What's Next?
Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) shares reached a new 52-week low during trading on Friday. The company traded as low as $37.18 and last traded at $37.80, with a volume of 15660 shares. The stock had previously closed at $57.67.
BSE Sensex: Top losers today
From the Sensex pack, Eternal, ICICI Bank, Axis Bank, UltraTech Cement, HDFC Bank, State Bank of India, Bajaj Finserv, and Larsen & Toubro were among the major laggards. Bharat Electronics, Reliance Industries, Sun Pharma, NTPC, Infosys, and HCL…
Spyglass Pharma, Inc. (NASDAQ:SGP) Receives Consensus Recommendation of 'Moderate Buy' from Analysts
Spyglass Pharma, Inc. (NASDAQ:SGP - Get Free Report) has earned a consensus rating of 'Moderate Buy' from the five brokerages that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a…
Spyglass Pharma (NASDAQ:SGP) Rating Increased to Hold at Zacks Research
Spyglass Pharma (NASDAQ:SGP - Get Free Report) was upgraded by investment analysts at Zacks Research to a 'hold' rating in a research note issued on Wednesday, Zacks.com reports. Several other brokerages have also commented on SGP. Wall Street Zen…
GW&K Investment Management LLC Takes Position in BridgeBio Pharma, Inc. $BBIO
GW&K Investment Management LLC purchased a new position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased…
Stock Market Today March 6, 2026: Sensex, Nifty tank over 1%
Escalating West Asia tensions and rising crude oil prices triggered a significant fall in the Sensex and Nifty, impacting Indian stock market sentiment. Sensex and Nifty fell sharply due to escalating West Asia tensions and rising crude oil prices.
Receive a Daily briefing on Pharma Industry News
Get Started